首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2578476篇
  免费   199870篇
  国内免费   33097篇
耳鼻咽喉   32378篇
儿科学   75770篇
妇产科学   63954篇
基础医学   346506篇
口腔科学   67788篇
临床医学   250844篇
内科学   487665篇
皮肤病学   55981篇
神经病学   193943篇
特种医学   103571篇
外国民族医学   696篇
外科学   374201篇
综合类   118693篇
现状与发展   89篇
一般理论   682篇
预防医学   195456篇
眼科学   59081篇
药学   204215篇
  443篇
中国医学   28768篇
肿瘤学   150719篇
  2022年   20445篇
  2021年   32813篇
  2020年   23473篇
  2019年   26773篇
  2018年   34154篇
  2017年   29095篇
  2016年   31289篇
  2015年   39594篇
  2014年   52508篇
  2013年   66251篇
  2012年   88382篇
  2011年   96028篇
  2010年   60815篇
  2009年   55413篇
  2008年   81453篇
  2007年   85305篇
  2006年   85843篇
  2005年   82308篇
  2004年   73104篇
  2003年   70918篇
  2002年   66364篇
  2001年   119754篇
  2000年   123001篇
  1999年   104142篇
  1998年   31912篇
  1997年   28789篇
  1996年   28437篇
  1995年   27827篇
  1994年   25431篇
  1993年   23046篇
  1992年   79211篇
  1991年   76649篇
  1990年   74134篇
  1989年   71010篇
  1988年   65019篇
  1987年   63580篇
  1986年   59823篇
  1985年   56969篇
  1984年   42357篇
  1983年   35606篇
  1982年   21173篇
  1979年   37926篇
  1978年   26645篇
  1977年   23046篇
  1976年   20674篇
  1975年   22330篇
  1974年   26129篇
  1973年   25108篇
  1972年   23518篇
  1971年   21849篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.

Background

Chronic limb-threatening ischemia (CLTI), defined as ischemic rest pain or tissue loss secondary to arterial insufficiency, is caused by multilevel arterial disease with frequent, severe infrageniculate disease. The rise in CLTI is in part the result of increasing worldwide prevalence of diabetes, renal insufficiency, and advanced aging of the population. The aim of this study was to compare a bypass-first with an endovascular-first revascularization strategy in patients with CLTI due to infrageniculate arterial disease.

Methods

We reviewed the American College of Surgeons National Surgical Quality Improvement Program targeted lower extremity revascularization database from 2012 to 2015 to identify patients with CLTI and isolated infrageniculate arterial disease who underwent primary infrageniculate bypass or endovascular intervention. We excluded patients with a history of ipsilateral revascularization and proximal interventions. The end points were major adverse limb event (MALE), major adverse cardiovascular event (MACE), amputation at 30 days, reintervention, patency, and mortality. Multivariable logistic regression was used to determine the association of a bypass-first or an endovascular-first intervention with outcomes.

Results

There were 1355 CLTI patients undergoing first-time revascularization to the infrageniculate arteries (821 endovascular-first revascularizations and 534 bypass-first revascularizations) identified. There was no significant difference in adjusted rate of 30-day MALE in the bypass-first vs endovascular-first revascularization cohort (9% vs 11.2%; odds ratio [OR], 0.73; 95% confidence interval [CI], 0.50-1.08). However, the incidence of transtibial or proximal amputation was lower in the bypass-first cohort (4.3% vs 7.4%; OR, 0.60; CI, 0.36-0.98). Patients with bypass-first revascularization had higher wound complication rates (9.7% vs 3.7%; OR, 2.75; CI, 1.71-4.42) compared with patients in the endovascular-first cohort. Compared with the endovascular-first cohort, the incidence of 30-day MACE was significantly higher in bypass-first patients (6.9% vs 2.6%; adjusted OR, 3.88; CI, 2.18-6.88), and 30-day mortality rates were 3.23% vs 1.8% (adjusted OR, 2.77; CI, 1.26-6.11). There was no difference in 30-day untreated loss of patency, reintervention of treated arterial segment, readmissions, and reoperations between the two cohorts. In subgroup analysis after exclusion of dialysis patients, there was also no significant difference in MALE or amputation between the bypass-first and endovascular-first cohorts.

Conclusions

CLTI patients with isolated infrageniculate arterial disease treated by a bypass-first approach have a significantly lower 30-day amputation. However, this benefit was not observed when dialysis patients were excluded. The bypass-first cohort had a higher incidence of MACE compared with an endovascular-first strategy. These results reaffirm the need for randomized controlled trials, such as the Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL-2) trial and Best Endovascular vs Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI), to provide level 1 evidence for the role of endovascular-first vs bypass-first revascularization strategies in the treatment of this population of challenging patients.  相似文献   
42.
缺血性卒中和短暂性脑缺血发作的二级预防指南的新认识   总被引:11,自引:0,他引:11  
2006年2月,美国卒中协会主办的国际卒中大会和当月出版的Stroke颁布了新的卒中和短暂性脑缺血发作(transient ischemic attack,TIA)二级预防指南[1,2]。新指南撰写委员会主席、美国哥伦比亚大学Sacco教授强调,与以前的指南[3,4]相比,新指南有了新的改进,它是一个以充分和完整证  相似文献   
43.
44.
Type 1 diabetes is one of the commonest chronic disorders encountered in children and adolescents. When it first becomes apparent in children, approximately 20% of them have clinical and biochemical signs of ketoacidosis (DKA). In the presence of unusual clinical symptoms it is necessary to consider the possibility of associated conditions, such as coeliac disease, immunothyroiditis and Addison’s disease. Children with diabetes must be treated by a multidisciplinary team made up of paediatrician, paediatric diabetes specialist, psychologist, social worker, ophthalmologist, dietitian, nurse and diabetes counsellor, making it essential for them to be treated in regional specialised centres. They are treated in their own psychosocial environment and their families are involved in the therapy. Comprehensive, multidisciplinary treatment strategies have now made it possible for these patients to enjoy normal physical wellbeing and near-normal psychosocial development. Prevention and early treatment of of disturbances associated with diabetes remain an important concern. The fact that type 2 diabetes must now be looked for in overweight children and adolescents is a new aspect of diabetes medicine.  相似文献   
45.
Conclusion  Several quality-control measures take place before (patient and camera preparation) and during SPECT acquisition to achieve high-quality images. Not uncommonly, technologists and physicians are left with suboptimal images that have to be addressed to reach the “right answer” for patient diagnosis and hence management. In many cases patients may be reimaged, especially if the problem is detected early, but in other cases either the patient has left the nuclear laboratory or there is an inevitable problem that, even with reimaging, will not be resolved. In these situations the technologist and physician have to seek the available techniques to obtain the best images possible. These resources are discussed in this issue as an aid in quality control to obtain the best possible images.  相似文献   
46.
47.
48.
49.
50.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号